- Hanks GE, Martz KL, Diamond JJ. The effect of dose on local control of prostate cancer. Int J Radiat Oncol Biol Phys 1988; 15: 1299-305.
- Dearnaley DP, Khoo VS, Norman AR, et al. Comparison of radiation side effects of conformai and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 1999; 353: 267-72.
- Zelefsky MJ, Cowen D, Fuks Z, et al. Long term tolerance of high dose three-dimensional conformai radiotherapy in patients with localized prostate carcinoma. Cancer 1999; 85: 2460-8.
- Hanks GE, Hanlon AL, Pinover WH, et al. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformai radiotherapy. Cancer J Sci Am 1999; 5: 152-8.
- Valicenti R, Jiandong JL, Pilepich M, et al. Survival advantage from higher-dose radiation therapy for clinical localized prostate cancer treated on the radiation therapy oncology group trials. J Clin Oncol 2000; 18: 2740-6.
- Horwitz EM, Hanlon AL, Hanks GE. Update on the treatment of prostate cancer with external beam irradiation. Prostate 1998; 37: 195-206.
- Shipley WU, Verhey LJ, Munzenrider JE, et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformai protons compared with conventional dose irradiation using photons alone. Int Radiat Oncol Biol Phys 1995; 32: 3-12.
- Kutcher GJ, Leibel SA, Ling CC, et al. New wine in an old bottle? Dose escalation under dose-volume constraints: a model of conformai therapy of the prostate. Int J Radiat Oncol Biol Phys 1996; 35: 415-6.
- Boersma LJ, van-den-Brink M, Bruce AM, et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformai radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 1998; 41: 83-92.
- Dale E, Olsen DR, Fossa SD. Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformai radiotherapy. Int J Radiat Oncol Biol Phys 1999;43:385-91.
- Yang FE, Chen GT, Ray P, et al. The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformai treatment planning for stage C prostate cancer. Int J Radiat Oncol Biol Phys 1995; 33: 1009-17.
- Forman JD, Kumar R, Haas G, et al. Neoadjuvant hormonal downsizing of localized carcinoma of the prostate: effects on the volume of normal tissue irradiation. Cancer Invest 1995; 13: 8-15.
- Zelefsky MJ, Harrison A. Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy. Urology 1997; 49: 38-45.
- Lebesque JV, Bruce AM, Kroes AP, et al. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. Int J Radiat Oncol Biol Phys 1995; 33: 1109-19.
- Shearer RJ, Davies JH, Gelister JS, et al. Hormonal cytoreduction and radiotherapy for carcinoma of the prostate. Br J Urol 1992; 69: 521-4.
- Lavierdiere J, Gomez JL, Cusan L, et al. Beneficial effect of combination hormonal therapy administered prior to and following external radiation therapy in localized prostate cancer. Int J Radiat Oncol Biol Phys 1997; 37: 247-52.
- Lilleby W, Knutsen B, Fossa SD, et al. Computed tomograph/magnetic resonance based volume changes of the primary tumour in patients with prostate cancer with or without androgen deprivation. Radiother Oncol 2000; 57: 193-8.
- Mostofi FK, Sesterhenn I, Sobin LH. Histological typing of prostate tumours. World Health Organization 1982; 15-23.
- Lilleby W, Fossa SD, Waehre HR, et al. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys 1999; 43: 735-43.
- Zagars GK, Pollack A, Smith LG. Conventional external-beam radiation therapy alone or with androgen ablation for clinical stage III (T3, NX/NO, MO) adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1999; 44: 809-19.
- Storey MR, Pollack A, Zagars G, et al. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 2000; 48: 635-42.
Free access
Changes in Treatment Volume of Hormonally Treated and Untreated Cancerous Prostate and its Impact on Rectal Dose
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.